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Summary
Objective: Recent studies have demonstrated that articular cartilage injury leads to chondrocyte death through a mechanism termed ‘‘apopto-
sis’’, or programmed cell death (PCD). Inhibitors of caspases, key enzymatic mediators of apoptosis, have been shown to block chondrocyte
PCD. We hypothesized that short-term intra-articular administration of a potent caspase inhibitor would decrease chondrocyte PCD and sub-
sequent cartilage degeneration following experimental osteochondral injury in rabbits.
Methods: Adult New Zealand white rabbits were subjected to osteochondral injuries of their femoral condyles. Knees in the treatment group
received daily intra-articular injections of the broad-spectrum caspase inhibitor Z-VAD-fmk for 7 days, while the control group received injec-
tions of vehicle alone. Seven days postinjury, one group of rabbits was sacriﬁced to assess levels of chondrocyte PCD. A second group was
sacriﬁced 42 days postinjury for histological evaluation to measure cartilage degeneration and cartilage repair.
Results: Seven days postinjury, there was a 45% reduction in chondrocyte PCD in the caspase inhibitor treated knees as compared to con-
trols (P¼ 0.01). Forty-two days postinjury, treated knees were found to have 17.9% greater chondrocyte survival (P< 0.01) and 7.6% greater
articular cartilage thickness (P¼ 0.01).
Conclusions: Intra-articular administration of the caspase inhibitor Z-VAD-fmk effectively blocks chondrocyte PCD following experimental
osteochondral injury in this model. Inhibition of chondrocyte PCD rescues chondrocytes that would otherwise die, limiting subsequent cartilage
loss. To our knowledge, this study is the ﬁrst to demonstrate that short-term inhibition of chondrocyte PCD leads to long-term preservation of
cartilage in vivo.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Recent studies have shown that acute cartilage injury induces
programmed cell death (PCD), which may contribute to the
subsequent development of posttraumatic arthritis1e3. PCD
is a highly regulated process, quite distinct from necrotic cell
death, and is characterized by activation of speciﬁc biochem-
ical pathways. Increased levels of chondrocyte PCD have
been noted in both osteoarthritis and rheumatoid arthritis4e8.
Analyses of human cartilage specimens following intra-articu-
lar fractures also showed markedly increased levels of chon-
drocyte PCD2,9. Provocatively, several studies have
demonstrated that PCD can be blocked with various drugs
and growth factors10e13. These ﬁndings suggest that apopto-
sis inhibition may be a useful therapeutic approach for the
treatment of cartilage injury by limiting chondrocyte loss.
A common feature of apoptotic pathways is caspase ac-
tivation. Caspases (cysteinyl aspartate-speciﬁc proteases)
are key enzymatic mediators of PCD. Upon activation, cas-
pases cleave a number of cellular proteins including poly
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ment binding protein), and nuclear mitotic apparatus pro-
teins, which ultimately leads to cell death. Caspase
inhibition has been shown to block PCD in many experi-
mental systems including neurodegenerative disease, solid
organ injury, and mechanical and chemical cartilage injury
models10,14. Studies have shown that caspase inhibitors
are particularly effective at limiting chondrocyte PCD, both
in vitro and in vivo11,13,14. These previous studies, however,
only examined the short-term effects of caspase inhibition
on chondrocyte PCD. The broader question of whether or
not short-term PCD inhibition results in long-term preserva-
tion of chondrocytes and cartilage in vivo remained, to our
knowledge, unanswered.
The purpose of this study was to test the long-term (6
weeks) effects of intra-articular caspase inhibition in vivo.
Speciﬁcally, we tested the hypothesis that 7 days of intra-artic-
ular caspase inhibitor treatment would increase chondrocyte
survival and preserve cartilage thickness in rabbits subjected
to experimental osteochondral injuries. Furthermore, we ex-
amined the effects of caspase inhibitor treatment on the qual-
ity of cartilage repair within the osteochondral defects.
Method
Twenty-nine adult (3.0e3.3 kg) New Zealand white rabbits
(Western Oregon Rabbit Company, OR) were anesthetized26
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amine (100 mg/kg). Preoperative antibiotics (Trimethoprime
Sulfadiazine, 30 mg/kg) and analgesic (Buprenorphine,
0.01 mg/kg) were also given. After adequate anesthesia
was achieved, the surgical site was shaved and prepped
with Betadine. A medial parapatellar approach was then
used to access the joint space. Care was taken to preserve
the collateral ligaments as well as the extensor mechanism.
Next, a cooled 2 mm drill bit was used to create 2e3 mm
deep osteochondral injuries to the weight bearing portions
of both the medial and lateral femoral condyles. One injury
was created in each condyle (Fig. 1).
To insure consistent drug delivery into the knee joint,
a soft polyethylene intra-articular 27 gauge catheter (Re-
CathCo, PA) was placed and then tunneled subcutaneously
to exit at the posterolateral thigh. Once the catheter was
veriﬁed to be patent, normal saline was used to irrigate
the joint, and the wound closed in layers using a running
4e0 nylon suture for the joint capsule and a running 3e0
nylon suture for the skin. The skin incision was further pro-
tected with cyanoacrylate gel. The wound was then ban-
daged loosely to protect the incision while allowing for
ﬂexion and extension at the knee joint.
Treated knees received daily intra-articular injections of
the caspase inhibitor Z-VAD-fmk (100 mM, 0.5 cc; Calbio-
chem, CA), while control knees received daily intra-articular
injections of vehicle (1%DMSO in phosphate buffered saline
(PBS), 0.5 cc) alone. Z-VAD-fmk is a cell permeable, irre-
versible, caspase inhibitor that has been used extensively
in PCD inhibition studies because of its effectiveness in
blocking the activity of multiple caspases10,12e14. Treatment
was initiated immediately after wound closure and was con-
tinued for a total of 7 days. Surgical sites were routinely
checked for infection or wound healing problems, and essen-
tial veterinary care was provided. Animals were allowed un-
restricted cage activity. Following the 7-day treatment
period, the catheters were removed. Five rabbits with bilat-
eral knee injuries (one knee treatment; and one knee control)
were euthanized on postoperative day 7 for PCD analysis;
24 rabbits with unilateral knee injuries (randomized to either
treatment or control) were euthanized on postinjury day 42
for histological analysis of cartilage degeneration and repair.
Fig. 1. Intraoperative photograph showing 2 mm drill holes placed
into the medial and lateral femoral condyles of rabbit hind limb
knees.Retrieved knee specimens were immediately ﬁxed in
zinc-buffered formalin (Z-ﬁx, Anatech LTD, MI) overnight
at 4(C. Following ﬁxation, specimens were decalciﬁed in
0.45 M ethylenediaminetetraacetic acid (EDTA) and 0.1 M
Tris, pH 8.0. The medial and lateral femoral condyles
were then split in the sagittal plane at the trochlear groove
and excess subchondral bone and soft tissues were re-
moved. These individual specimens were then dehydrated
through graded ethanol and xylene solutions and then em-
bedded into parafﬁn blocks. Sagittal sections were cut at
7 mm thickness on a rotary microtome and placed on Super-
frost Plus slides (Fisher Scientiﬁc, NH). Sections through
the central portion of the injury sites were identiﬁed by light
microscopy and were used for all subsequent analyses.
Each drill hole was treated as an independent specimen.
The area of analysis included the full thickness of articular
cartilage extending outwards 2.0 mm away from both
‘‘edges’’ of the injury site. The area of analysis was further
subdivided into 0.5 mm intervals radiating outwards from
the injury site with each zone encompassing the full thick-
ness of articular cartilage [Fig. 2(A)].
Sections from animals sacriﬁced at 7 days were stained
with the terminal deoxynucleotidyl transferase biotin-dUTP
nick end labeling (TUNEL) based ApopTag Fluorescein
Direct In Situ Apoptosis detection kit (Chemicon, CA). Mod-
iﬁcations to the manufacturer’s parafﬁn staining protocol
were made to optimize the sensitivity and speciﬁcity of the
protocol for use in parafﬁn embedded cartilage samples15.
Alterations to the supplied protocol included decreasing
the proteinase K concentration to 20 mg/ml, and the concen-
tration of the terminal deoxynucleotidyl transferase (TdT)
working solution to half of the kit default. An equal volume
of sterile PBS was used to dilute the working solution, which
consisted of the recommended 1 part TdT enzyme with 2
parts of the reaction buffer nucleotide mix. Slides were
counterstained with 40,60-diamidino-2-phenylindole (DAPI)
(Vector Labs, CA) which labels all cell nuclei. High-resolution
ﬂuorescent microscopic images were captured using
a Zeiss Axiocam digital camera using appropriate ﬁlters.
TUNEL positive [Fig. 2(B)] and DAPI positive cells were
quantiﬁed using semiautomated image analysis software
(Scion Image, SCION, MD; and Photoshop 6.0, Adobe,
CA). In brief, cells were isolated using Photoshop’s color
based ﬁltering. The images were down-sampled to a 1-bit
color, and transferred to Scion Image for counting based
upon parameters set for particle sizes that would represent
individual cells and not staining artifacts. An apoptotic index
was then calculated for each specimen by dividing the num-
ber of TUNEL positive cells by the total number of cells
identiﬁed by DAPI staining. To conﬁrm that the TUNEL
staining was speciﬁc for apoptotic cells, formamide induced
DNA denaturation with antibody detection of single-
stranded DNA segments was used as an alternative
method for evaluating the level of PCD16,17. Detection of
these single-stranded DNA segments relies upon the his-
tone instability of apoptotic cells, rather than the DNA frag-
mentation that is detected by TUNEL.
Sections from animals sacriﬁced at 42 days postinjury
were stained with Fast Green/Safranin O/Hematoxylin.
High-resolution image acquisition and semiautomated cell
counting were performed as described above. Cartilage
thickness was determined for each 0.5 mm interval of
each specimen using semiautomated image processing
techniques. Digital images were calibrated to 1 mm/pixel, al-
lowing for accurate measurement of cartilage thickness and
distance from injury. High-resolution transmitted light im-
ages were evaluated by a blinded investigator, and each
528 A. C. Dang et al.: Beneﬁcial effects of intra-articular caspase inhibition therapyFig. 2. (A) Schematic drawing of a histological section through the central portion of a drill hole. The drawing shows the relationship between
the drill hole injury, the articular cartilage, and bone. The area of analysis includes the full thickness of cartilage extending 2000 mm from the
edge of the drill injury, and is subdivided into 500 mm segments. (B) TUNEL images of histological section from specimen harvested 7 days
postinjury at 5. The bright green nuclei represent cells undergoing apoptosis. TUNEL signal was greatest immediately adjacent to the injury
edge. The image on the left represents the edge adjacent to injury, and the image on the right, a segment of cartilage away from injury.section scored using two well-described systems for as-
sessing cartilage repair: Pineda (1992), and O’Driscoll
(1986) (Tables I and II)18e20. The Pineda system grades
cartilage repair based upon the percent ﬁlling of the defect,
reconstruction of the osteochondral junction, matrix stain-
ing, and cell morphology. The O’Driscoll system grades car-
tilage repair based upon cellular morphology, Safranin O
staining, surface regularity, structural integrity, cartilage
thickness, bonding to adjacent tissue, cellularity, and pres-
ence of degenerative changes in adjacent cartilage.
Statistical analysis was performed using two-tailed un-
paired t-tests for cellular data and the ManneWhitney test
for histological data. Each drill hole was treated as an inde-
pendent specimen. Three near-adjacent sections from each
specimen were analyzed. Statistical comparisons were then
made between the treated and control groups using un-
paired, two-tailed t-tests with a threshold for signiﬁcance
set at P< 0.05. All data are presented as mean standard
error of the mean. All statistical analyses were performed
using GraphPad Prism (GraphPad, CA).
Results
All animals tolerated the surgeries well. Neither systemic
toxicity nor wound healing problems were noted in associa-
tion with caspase inhibitor treatment. All incisions wereintact at the time of harvest, and all animals exhibited
grossly preserved limb function. In animals sacriﬁced at 7
days, eight treated and 10 control specimens were ana-
lyzed. Two specimens from the treatment group were ex-
cluded due to excessive damage during processing. In
the animals sacriﬁced at 6 weeks, 22 treated and 21 control
specimens were available for analysis; two treatment spec-
imens and three control specimens were excluded due to
evidence of joint infection (one animal, two specimens) or
damage to the specimens during processing that prevented
accurate measurement of the cartilage thickness, or cell
counts, such as small folds or tears in the section (three
specimens).
After 7 days, treatment with Z-VAD-fmk reduced the apo-
ptotic index by 45% compared to controls (treated¼ 9.9
2.0%, control¼ 17.9 2.1%; P¼ 0.01). When the area of
analysis was subdivided into 0.5 mm intervals starting at
the edge of the injury site, a statistically signiﬁcant
(P< 0.05) reduction in the apoptotic index was observed
for the following intervals: 0e0.5 mm (treated¼ 22.9 5.1%,
control¼ 44.7 6.7%), 0.5e1.0 mm (treated¼ 5.9 1.4%,
control¼ 22.2 3.9%), and 1.0e1.5 mm (treated¼ 5.5
1.1%, control¼ 12.1 2.0%) (Fig. 3). Based upon compari-
son to our previous studies13, there was no evidence of
‘‘spill-over’’ effect of Z-VAD-fmk delivered to the treated
knee affecting PCD in the control knee.
529Osteoarthritis and Cartilage Vol. 14, No. 6In specimens obtained 42 days postinjury (35 days after
the end of Z-VAD-fmk administration), treated knees had
17.9% greater number of articular chondrocytes compared
to the untreated controls (P< 0.01). The differences in
chondrocyte number in each 0.5 mm interval measured
from the edge of the injury site were all statistically signiﬁ-
cant (P< 0.05): 0e0.5 mm (treated¼ 189.1 5.4, con-
trol¼ 143.1 6.5), 0.5e1.0 mm (treated¼ 227.6 4.6,
control¼ 197.5 7.0), 1.0e1.5 mm (treated¼ 244.7 4.8,
control¼ 210.8 6.7), and 1.5e2.0 mm (treated¼ 252.8
5.6, control¼ 223.1 7.5). The observed difference in
chondrocyte numbers was most pronounced in the region
immediately adjacent to the injury edge [Fig. 4(A)].
At 42 days postinjury, treated knees also had signiﬁcantly
greater articular cartilage thickness compared to controls,
with an overall difference of 7.1% (treated¼ 328.2 6.1 mm,
control¼ 304.9 7.3 mm; P¼ 0.01). Paralleling the results
obtained for chondrocyte numbers, differences in cartilage
thickness were most pronounced in the region immediately
adjacent to the injury site. With one exception, differences
in cartilage thickness for all zones were statistically signiﬁ-
cant (P< 0.05): immediately adjacent to the injury (treated¼
288.6 7.8 mm, control¼ 256.2 10.2 mm); 0.25 mm (trea-
ted¼ 316.4 6.4 mm, control¼ 295.4 7.8 mm); 0.75 mm
(treated¼ 333.1 6.2 mm, control¼ 312.2 7.7 mm); 1.25 mm
(treated¼ 340.2 7.8 mm, control¼ 317.9 8.0 mm); and
2.0 mm (treated¼ 350.5 9.2 mm, control¼ 321.5 8.3 mm)
away from the injury edge. At 1.75 mm away from injury, sta-
tistical signiﬁcance was not reached (treated¼ 344 8.7 mm,
control¼ 323 8.2 mm, P¼ 0.08) [Fig. 4(B)].
Histological analysis of cartilage repair tissue within the
injury sites demonstrated statistically signiﬁcant superiority
for Z-VAD-fmk treated specimens using two different scor-
ing systems. Using the Pineda system (lower score given
to superior result), treated knee scores averaged 4.0 0.4
while control knees averaged 5.2 0.3 (P< 0.05). Simi-
larly, using the O’Driscoll system (higher score given to
Table I
Pineda cartilage repair score
Characteristics Score
Filling of defect
125% 1
100% 0
75% 1
50% 2
25% 3
0% 4
Reconstruction of osteochondral junction
Yes 0
Almost 1
Not close 2
Matrix staining
Normal 0
Reduced staining 1
Signiﬁcantly reduced staining 2
Faint staining 3
No stain 4
Cell morphology
Normal 0
Most hyaline and ﬁbrocartilage 1
Mostly ﬁbrocartilage 2
Some ﬁbrocartilage, but mostly
nonchondrocytic cells
3
Nonchondrocytic cells only 4superior result), treated knees averaged 17.6 0.5 while
control knees averaged 14.9 0.5 (P< 0.05). In both
cases, the principal difference between groups was repair
tissue thickness. Other criteria such as cell morphology,
proteoglycan staining, integration of the repair tissue, or in-
tegrity of the articular surface or osteochondral junction did
not distinguish between the treated and control groups.
Complete healing of the subchondral bone and ﬁlling of
the cartilage defect were noted in all specimens of both
treated and untreated knees (Fig. 5). Histological analysis
of cartilage adjacent to the injury site did not show statisti-
cally signiﬁcant differences in parameters of cartilage de-
generation other than chondrocyte number and cartilage
thickness. Speciﬁcally, there were no clear differences in re-
gard to matrix integrity, proteoglycan content, or morpholog-
ical features such as ﬁbrillation.
Table II
O’Driscoll cartilage repair score
Characteristics Score
Nature of predominant tissue
Cellular morphology
Hyaline articular cartilage 4
Incompletely differentiated mesenchyme 2
Fibrous tissue or bone 0
Safranin-O staining of the matrix
Normal or nearly normal 3
Moderate 2
Slight 1
None 0
Structural characteristics
Surface regularity
Smooth and intact 3
Superﬁcial horizontal lamination 2
Fissures 25e100% of the thickness 1
Severe disruption, including ﬁbrillation 0
Structural integrity
Normal 2
Slight disruption, including cysts 1
Severe disintegration 0
Thickness
100% or normal adjacent cartilage 2
50e100% of normal cartilage 1
0e50% of normal cartilage 0
Bonding to the adjacent cartilage
Bonded at both ends of graft 2
Bonded at one end, or partially at both ends 1
Not bonded 0
Freedom from cellular changes of degeneration
Hypocellularity
Normal cellularity 3
Slight hypocellularity 2
Moderate hypocellularity 1
Severe hypocellularity 0
Chondrocyte clustering
No clusters 2
<25% of the cells 1
25e100% of the cells 0
Freedom from degenerative changes in adjacent cartilage
Normal cellularity, no clusters, normal staining 3
Normal cellularity, mild clusters, moderate staining 2
Mild or moderate hypocellularity, slight staining 1
Severe hypocellularity, poor or no staining 0
530 A. C. Dang et al.: Beneﬁcial effects of intra-articular caspase inhibition therapyFig. 4. (A) At 42 days postinjury, the number of articular chondro-
cytes was greater in treated animals in each interval, with an aver-
age difference of 17.9% (P< 0.01). The greatest difference of
32.1% was seen immediately adjacent to injury site (0e0.5 mm),
with statistically signiﬁcant (P< 0.05) differences at 0.5e1.0 mm,
1.0e1.5 mm, and at 1.5e2.0 mm. Statistically signiﬁcant measure-
ments are indicated by ‘‘*’’; error bars show standard errors of the
mean. (B) Cartilage thickness measured 42 days postinjury was
preserved in treated animals with an average difference of 7.6%
(P¼ 0.01). The greatest difference was observed immediately adja-
cent to the injury with a 12.7% difference. Statistically signiﬁcant dif-
ferences (P< 0.05) were also seen at 0.25 mm, 0.75 mm, 1.25 mm,
and 2.0 mm away from the injury edge.
Fig. 3. The apoptotic index (TUNEL positive cells/total cells) of the
treated knees measured 7 days postinjury. Overall PCD was re-
duced in treated knees by 45% (P¼ 0.01) measured from 0 mm
to 2.0 mm away from the edge of the drill hole. Statistically signif-
icant measurements (P< 0.05) are indicated by ‘‘*’’; error bars
show standard errors of the mean.Discussion
The major ﬁndings of this study are as follows: (1) the
short-term intra-articular administration of Z-VAD-fmk,
a broad-spectrum caspase inhibitor, blocks chondrocyte
PCD measured 7 days after osteochondral injury; and (2)
this short-term inhibition of PCD translates into long-term
preservation of articular chondrocytes and cartilage thick-
ness in vivo. The experimental results clearly indicate that
the observed decrease in apoptotic cells identiﬁed by TU-
NEL analysis on day 7 represents actual rescue of chondro-
cytes that would otherwise undergo PCD adjacent to the
injury site.
These results may be of considerable interest because
they provide proof of concept for a therapeutic strategy
based on early intervention designed to limit unnecessary
loss of chondrocytes through PCD inhibition. Multiple stud-
ies, including an analysis of cartilage specimens obtained
from patients after tibial plateau fractures, have demon-
strated that acute cartilage injury induces very high levels
of chondrocyte PCD2. This ﬁnding is not surprising since
multiple key mediators of chondrocyte PCD are present in
the acutely traumatized joint, including matrix damage, me-
chanical overload, inﬂammatory cells, reactive oxygen spe-
cies, proinﬂammatory cytokines, and blood12,14,21e23. The
marked upregulation of chondrocyte PCD appears to reach
a peak approximately 4 or 5 days after injury, with elevated
PCD levels observed for up to 2 weeks12,13. This early post-
injury time frame has been postulated to represent a window
of opportunity for therapeutic intervention. Interestingly, the
temporalespatial pattern of chondrocyte PCD noted after
experimental injury suggests that secondary injury cas-
cades and diffusible mediators generated from the injured
cartilage are responsible for much of the observed PCD24.
These mediators appear to cause propagation of chondro-
cyte PCD away from the original injury site leading to exten-
sion of the zone of injury. Therefore, successful inhibition of
chondrocyte PCD should not only rescue chondrocytes at
the site of injury, but may also limit chondrocyte loss in
the surrounding cartilage as well.
Since PCD is a normal occurrence in far-ranging biological
processes, we were particularly interested in possible detri-
mental effects on tissue healing, particularly healing within
the osteochondral injuries’ sites themselves. PCD is associ-
ated with multiple pathways critical to normal healing mech-
anisms in musculoskeletal tissues including the initial
inﬂammatory response as well as during endochondral ossi-
ﬁcation. Therefore, it is possible that inhibition of caspases
would lead to inferior healing in our model. We found that
intra-articular administration of Z-VAD-fmk at a very high dose
did not inhibit normal healing; in fact, Pineda and O’Driscoll
cartilage repair scores were slightly better for treated knees
primarily due to increased thickness of the cartilage repair
tissue. Multiple studies have shown that osteochondral
defects in this rabbit model heal with a mixture of ‘‘hyaline-
like’’ cartilage and ﬁbrocartilage, but not normal hyaline car-
tilage25. Our results were consistent with these prior studies.
Importantly, we found no detrimental effect of caspase in-
hibition on the incidence of infection or on the overall health
of the rabbits. This result emphasizes the beneﬁts of tar-
geted local delivery of the drug afforded by direct injection
into a closed joint space which minimizes the total amount
of drug administered and, therefore, potential systemic ef-
fects. For example, to achieve comparable intra-articular
drug concentrations, the amount of drug delivered system-
ically would likely need to be three to four orders of magni-
tude greater. However, even low doses of potent caspase
531Osteoarthritis and Cartilage Vol. 14, No. 6Fig. 5. (A) Photomicrograph (original magniﬁcation 25) of Safranin O/Fast Green/Hematoxylin stained section from a treated specimen 42
days after injury. The subchondral plate is continuous across the injury, and the cartilage defect has ﬁlled in with ﬁbrocartilage. The red bar
represents 500 mm. (B) Gross image of the articular surface of a treated specimen at 6 weeks. All cartilage defects had ﬁlled in, and the sur-
rounding cartilage was grossly normal, without ﬁbrillation or eburnation in either treated or control groups.inhibitors such as Z-VAD-fmk may have toxic effects in hu-
mans that cannot be anticipated, and its clinical utility obvi-
ously cannot be determined without actual clinical trials.
The conclusions from this study are applicable not only to
osteochondral injuries, but also to other types of acute car-
tilage trauma. Increased levels of chondrocyte PCD have
been documented in biopsy samples from human knees af-
ter isolated chondral injuries2. Furthermore, almost any sur-
gical intervention designed to repair or replace articular
cartilage involves some degree of mechanical injury to the
surrounding cartilage. This iatrogenic damage induces cell
death in the adjacent cartilage26, some of which is certainly
due to PCD. Therefore, PCD inhibition therapies may prove
useful not only for the prevention of cartilage degeneration,
but also for optimizing the surgical treatment of cartilage in-
juries. Based upon the results of this study, we conclude
that intra-articular administration of PCD inhibition is a prom-
ising therapeutic strategy, and that future efforts should be
directed at determining the optimal anti-PCD agent(s), dos-
ing, delivery methods, and timing and duration of treatment,
as well as the long-term effects on joint function.
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